Tag: comes-two
-
FDA highlights liver safety issues in Cempra drug review
(Reuters) – Cempra Inc’s experimental drug to treat community acquired pneumonia, the kind suffered by presidential candidate Hillary Clinton recently, causes a potentially concerning rise in liver enzymes, according to a preliminary review by the U.S. Food and Drug Administration. The review, posted on the FDA’s website on Wednesday, comes two days ahead of a…